Tag: Targeted Cancer Therapy

α-Lipoic acid inhibits human lung cancer cell proliferation through Grb2-mediated EGFR downregulation

The study titled “α-Lipoic acid inhibits human lung cancer cell proliferation through Grb2-mediated EGFR downregulation” (Biochem Biophys Res Commun, 2017, PMID: 28993193) is an in vitro/animal study investigating the effects of α-lipoic acid (α-LA) on non-small cell lung cancer (NSCLC) cells. The findings indicate that α-LA suppresses NSCLC cell proliferation

Read More »